Nancy Phelan

CA·SEDI

Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 29 Sept 2025 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €34k.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Nancy Phelan: trading record in brief

Nancy Phelan is a declared insider of Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), with filings sourced from SEDI. We count 3 filings; the first trade dates from 21 September 2023 and the latest from 25 September 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 29 September 2025 came the latest disclosure, an option exercise for €34k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The median gap between a trade and its publication by SEDI is 4 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.